Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
暂无分享，去创建一个
K. Ohta | J. Kanda | M. Hino | J. Kuroda | I. Matsumura | Y. Kanakura | Y. Adachi | A. Takaori-Kondo | S. Nomura | S. Yoshihara | N. Uoshima | H. Shibayama | Y. Shimura | H. Uchiyama | C. Shimazaki | Hirokazu Tanaka | H. Hanamoto | S. Kosugi | A. Nakaya | Hideo Yagi | S. Fuchida | H. Kaneko | Y. Shimazu | M. Matsuda | Ryosuke Yamamura | Yoshiyuki Onda | T. Itou